Key points are not available for this paper at this time.
, with a focus on also systemic effects. When cell-specific treatments become feasible, this information will be crucial for determining the best metabolic intervention to improve atherosclerosis and its interplay with co-morbidities.
Dai et al. (Mon,) studied this question.